177 related articles for article (PubMed ID: 8706245)
1. Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder.
Rao KV; Detrisac CJ; Steele VE; Hawk ET; Kelloff GJ; McCormick DL
Carcinogenesis; 1996 Jul; 17(7):1435-8. PubMed ID: 8706245
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
Grubbs CJ; Lubet RA; Koki AT; Leahy KM; Masferrer JL; Steele VE; Kelloff GJ; Hill DL; Seibert K
Cancer Res; 2000 Oct; 60(20):5599-602. PubMed ID: 11059745
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention by indomethacin of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumors.
Grubbs CJ; Juliana MM; Eto I; Casebolt T; Whitaker LM; Canfield GJ; Manczak M; Steele VE; Kelloff GJ
Anticancer Res; 1993; 13(1):33-6. PubMed ID: 8476227
[TBL] [Abstract][Full Text] [Related]
4. 4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin.
Lubet RA; Huebner K; Fong LY; Altieri DC; Steele VE; Kopelovich L; Kavanaugh C; Juliana MM; Soong SJ; Grubbs CJ
Carcinogenesis; 2005 Mar; 26(3):571-8. PubMed ID: 15591090
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive efficacy of piroxicam administered alone or in combination with lycopene and beta-carotene on the development of rat urinary bladder carcinoma after N-butyl-N-(4-hydroxybutyl)nitrosamine treatment.
Okajima E; Ozono S; Endo T; Majima T; Tsutsumi M; Fukuda T; Akai H; Denda A; Hirao Y; Okajima E; Nishino H; Nir Z; Konishi Y
Jpn J Cancer Res; 1997 Jun; 88(6):543-52. PubMed ID: 9263531
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of OH-BBN-induced bladder cancer in mice by oltipraz, alone and in combination with 4-HPR and DFMO.
Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC
Anticancer Res; 1994; 14(1A):5-11. PubMed ID: 8166455
[TBL] [Abstract][Full Text] [Related]
7. Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer model.
Nicastro HL; Grubbs CJ; Margaret Juliana M; Bode AM; Kim MS; Lu Y; You M; Milne GL; Boring D; Steele VE; Lubet RA
Cancer Prev Res (Phila); 2014 Feb; 7(2):246-54. PubMed ID: 24346344
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of urinary bladder carcinogenesis by the natural phenolic compound protocatechuic acid in rats.
Hirose Y; Tanaka T; Kawamori T; Ohnishi M; Makita H; Mori H; Satoh K; Hara A
Carcinogenesis; 1995 Oct; 16(10):2337-42. PubMed ID: 7586132
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis.
Iida K; Itoh K; Kumagai Y; Oyasu R; Hattori K; Kawai K; Shimazui T; Akaza H; Yamamoto M
Cancer Res; 2004 Sep; 64(18):6424-31. PubMed ID: 15374950
[TBL] [Abstract][Full Text] [Related]
10. Suppressive effect of 1,4-phenylene diisothiocyanate on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
Sugie S; Vinh PQ; Rahman KM; Ushida J; Kohno H; Suzuki R; Hara A; Quang le B; Tanaka T; Mori H
Int J Cancer; 2005 Nov; 117(4):524-30. PubMed ID: 15929075
[TBL] [Abstract][Full Text] [Related]
11. Dietary beta-cryptoxanthin inhibits N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
Miyazawa K; Miyamoto S; Suzuki R; Yasui Y; Ikeda R; Kohno H; Yano M; Tanaka T; Hata K; Suzuki K
Oncol Rep; 2007 Feb; 17(2):297-304. PubMed ID: 17203164
[TBL] [Abstract][Full Text] [Related]
12. Chemopreventive effects of a flavonoid antioxidant silymarin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
Vinh PQ; Sugie S; Tanaka T; Hara A; Yamada Y; Katayama M; Deguchi T; Mori H
Jpn J Cancer Res; 2002 Jan; 93(1):42-9. PubMed ID: 11802807
[TBL] [Abstract][Full Text] [Related]
13. N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids.
Becci PJ; Thompson HJ; Strum JM; Brown CC; Sporn MB; Moon RC
Cancer Res; 1981 Mar; 41(3):927-32. PubMed ID: 7459879
[TBL] [Abstract][Full Text] [Related]
14. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice.
Tyagi A; Raina K; Singh RP; Gu M; Agarwal C; Harrison G; Glode LM; Agarwal R
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3248-55. PubMed ID: 18089718
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Okazaki K; Yamagishi M; Son HY; Imazawa T; Furukawa F; Nakamura H; Nishikawa A; Masegi T; Hirose M
Nutr Cancer; 2002; 42(2):211-6. PubMed ID: 12416262
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of mouse urinary bladder carcinogenesis by fermented brown rice and rice bran.
Kuno T; Hirose Y; Yamada Y; Hata K; Qiang SH; Asano N; Oyama T; Zhi H; Iwasaki T; Kobayashi H; Mori H
Oncol Rep; 2006 Mar; 15(3):533-8. PubMed ID: 16465408
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Becci PJ; Thompson HJ; Grubbs CJ; Squire RA; Brown CC; Sporn MB; Moon RC
Cancer Res; 1978 Dec; 38(12):4463-6. PubMed ID: 719631
[TBL] [Abstract][Full Text] [Related]
18. Influence of total dose and dose schedule on induction of urinary bladder cancer in the mouse by N-butyl-N-(4-hydroxybutyl)nitrosamine.
McCormick DL; Ronan SS; Becci PJ; Moon RC
Carcinogenesis; 1981; 2(3):251-4. PubMed ID: 7273310
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin.
Tanaka T; Morishita Y; Suzui M; Kojima T; Okumura A; Mori H
Carcinogenesis; 1994 Jan; 15(1):15-9. PubMed ID: 8293542
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocols.
Castonguay A; Rioux N
Carcinogenesis; 1997 Mar; 18(3):491-6. PubMed ID: 9067547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
